Evidence map›Paper›PMID 37764890›Full record

ArticlePathogens (Basel, Switzerland)2023

Two Commercially Available Blood-Stabilization Reagents Serve as Potent Inactivators of Coronaviruses.

Joseph J O'Connor, Lynden Voth, Jeremiah Athmer, Nicholas M George, Christopher M Connelly, Anthony R Fehr

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joseph J O'ConnorDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA.
Lynden VothDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA.ORCID 0000-0003-0451-6066
Jeremiah AthmerStreck LLC, 7002 S. 109th Street, La Vista, Omaha, NE 68128, USA.
Nicholas M GeorgeStreck LLC, 7002 S. 109th Street, La Vista, Omaha, NE 68128, USA.
Christopher M ConnellyStreck LLC, 7002 S. 109th Street, La Vista, Omaha, NE 68128, USA.
Anthony R FehrDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA.ORCID 0000-0003-1560-1573
University of Kansas · US

Funding

Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
NIGMS NIH HHS P20 GM113117
6 · The paper itself

Abstract

The continued circulation of SARS-CoV-2 and the increasing frequency of coronavirus (CoV) outbreaks over the decades demonstrates the enduring threat that the CoV family poses. There remains a significant need to develop tools to monitor and prevent the spread of these viruses. We tested blood-stabilization reagents from two commercially available blood collection tubes (BCTs) for their ability to inactivate three different coronaviruses (MHV, OC-43, and SARS-CoV-2) and stabilize their RNA. Both Cell-Free DNA BCT

Indexed as

blood collection reagentscoronavirusRNA stabilizationSARS-CoV-2

Identifiers

PMID37764890
PMCPMC10534660
OpenAlexW4386161565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.